Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Middle East and Africa Radiotherapy Market - Industry Trends and Forecast To 2027

Published by Data Bridge Market Research Private Limited Product code 961962
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
Middle East and Africa Radiotherapy Market - Industry Trends and Forecast To 2027
Published: August 1, 2020 Content info: 90 Pages
Description

Middle East and Africa radiotherapy market is projected to register a CAGR of 3.8% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Middle East and Africa Radiotherapy Market By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/Radiopharmaceuticals & Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software & Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer & Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics & Others), Distribution Channel (Direct Tender, Retail Sales & Others), Country (South Africa, Saudi Arabia, UAE, Israel, Egypt & Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Middle East and Africa radiotherapy market are:

Growing healthcare infrastructure

Increasing adoption of advance technology based equipment

Market Players:

The key market players for Middle East and Africa radiotherapy market are listed below:

Varian Medical Systems, Inc.

Siemens Healthcare GmbH

Elekta AB

RaySearch Laboratories

Brainlab AG

Koninklijke Philips N.V.

GE Healthcare

Hitachi, Ltd.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, MARKET SHARE ANALYSIS
    • 4.1.1 MARKET SHARE ANALYSIS: MIDDLE EAST AND AFRICA
    • 4.1.2 MARKET SHARE ANALYSIS: NORTH AMERICA
      • 4.1.2.1 MARKET SHARE ANALYSIS: U.S.
      • 4.1.2.2 MARKET SHARE ANALYSIS: CANADA
      • 4.1.2.3 MARKET SHARE ANALYSIS: MEXICO
    • 4.1.3 MARKET SHARE ANALYSIS: EUROPE
      • 4.1.3.1 MARKET SHARE ANALYSIS: GERMANY
      • 4.1.3.2 MARKET SHARE ANALYSIS: FRANCE
      • 4.1.3.3 MARKET SHARE ANALYSIS: ITALY
      • 4.1.3.4 MARKET SHARE ANALYSIS: U.K.
      • 4.1.3.5 MARKET SHARE ANALYSIS: SPAIN
      • 4.1.3.6 MARKET SHARE ANALYSIS: RUSSIA
      • 4.1.3.7 MARKET SHARE ANALYSIS: NETHERLANDS
      • 4.1.3.8 MARKET SHARE ANALYSIS: SWITZERLAND
      • 4.1.3.9 MARKET SHARE ANALYSIS: BELGIUM
      • 4.1.3.10 MARKET SHARE ANALYSIS: TURKEY
      • 4.1.3.11 MARKET SHARE ANALYSIS: UKRAINE
    • 4.1.4 MARKET SHARE ANALYSIS: ASIA-PACIFIC
      • 4.1.4.1 MARKET SHARE ANALYSIS: CHINA
      • 4.1.4.2 MARKET SHARE ANALYSIS: JAPAN
      • 4.1.4.3 MARKET SHARE ANALYSIS: INDIA
      • 4.1.4.4 MARKET SHARE ANALYSIS: AUSTRALIA
      • 4.1.4.5 MARKET SHARE ANALYSIS: SOUTH KOREA
      • 4.1.4.6 MARKET SHARE ANALYSIS: INDONESIA
      • 4.1.4.7 MARKET SHARE ANALYSIS: THAILAND
      • 4.1.4.8 MARKET SHARE ANALYSIS: SINGAPORE
      • 4.1.4.9 MARKET SHARE ANALYSIS: MALAYSIA
      • 4.1.4.10 MARKET SHARE ANALYSIS: PHILIPPINES
    • 4.1.5 MARKET SHARE ANALYSIS: SOUTH AMERICA
      • 4.1.5.1 MARKET SHARE ANALYSIS: BRAZIL
      • 4.1.5.2 MARKET SHARE ANALYSIS: ARGENTINA
      • 4.1.5.3 MARKET SHARE ANALYSIS: CHILE
    • 4.1.6 MARKET SHARE ANALYSIS: MIDDLE EAST AND AFRICA
      • 4.1.6.1 MARKET SHARE ANALYSIS: SOUTH AFRICA
      • 4.1.6.2 MARKET SHARE ANALYSIS: SAUDI ARABIA
      • 4.1.6.3 MARKET SHARE ANALYSIS: UAE
      • 4.1.6.4 MARKET SHARE ANALYSIS: EGYPT
      • 4.1.6.5 MARKET SHARE ANALYSIS: ISRAEL
  • 4.2 MIDDLE EAST AND AFRICA PROTON BEAM THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.2.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
    • 4.2.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.2.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.2.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.2.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.2.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.2.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.2.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.2.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.2.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.2.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.2.4.1 company share analysis: CHINA
      • 4.2.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.2.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.2.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.3 MIDDLE EAST AND AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.3.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
    • 4.3.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.3.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.3.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.3.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.3.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.3.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.3.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.3.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.3.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.3.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.3.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.3.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.3.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.3.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.4 MIDDLE EAST AND AFRICA IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.4.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
    • 4.4.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.4.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.4.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.4.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.4.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.4.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.4.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.4.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.4.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.4.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.4.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.4.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.4.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.4.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.5 MIDDLE EAST AND AFRICA STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.5.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
    • 4.5.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.5.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.5.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.5.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.5.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.5.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.5.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.5.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.5.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.5.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.5.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.5.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.5.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.5.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA

5 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET

  • 5.1 IMPACT ANALYSIS ON DEMAND
  • 5.2 CONCLUSION

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 GROWING PREVALENCE OF CANCER DISEASE
    • 6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
    • 6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
    • 6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
  • 6.2 RESTRAINTS
    • 6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    • 6.2.2 COMPLEX NATURE OF RADIOTHERAPY
    • 6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURES
  • 6.3 OPPORTUNITIES
    • 6.3.1 INCREASING HEALTHCARE EXPENDITURES FOR CANCER TREATMENTS
    • 6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT
    • 6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
  • 6.4 CHALLENGES
    • 6.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
    • 6.4.2 RISK OF RADIATION EXPOSURE

7 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 EXTERNAL-BEAM RADIATION THERAPY
    • 7.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
    • 7.2.2 PROTON BEAM THERAPY
    • 7.2.3 STEREOTACTIC RADIATION THERAPY
    • 7.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
    • 7.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
    • 7.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
    • 7.2.7 OTHERS
  • 7.3 INTERNAL RADIATION THERAPY
    • 7.3.1 BRACHYTHERAPY
    • 7.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
    • 7.3.3 BRACHYTHERAPY
      • 7.3.3.1 HIGH DOSE BRACHYTHERAPY
      • 7.3.3.2 LOW DOSE BRACHYTHERAPY
  • 7.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
  • 7.5 OTHERS

8 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT

  • 8.1 OVERVIEW
  • 8.2 EXTERNAL BEAM RADIOTHERAPY
    • 8.2.1 LINAC
    • 8.2.2 PROTON THERAPY
    • 8.2.3 CYBER KNIFE
    • 8.2.4 GAMMA KNIFE
    • 8.2.5 OTHERS
  • 8.3 INTERNAL RADIOTHERAPY PRODUCTS
    • 8.3.1 SEEDS
    • 8.3.2 AFTERLOADERS
    • 8.3.3 OTHERS
  • 8.4 RADIOTHERAPY SOFTWARE
    • 8.4.1 IMAGE GUIDING SOFTWARE
    • 8.4.2 TREATMENT PLANNING SOFTWARE
    • 8.4.3 PATIENT POSITIONING SOFTWARE
    • 8.4.4 DOSAGE PLANNING SOFTWARE
    • 8.4.5 OTHERS

9 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 BREAST CANCER
  • 9.3 LUNG CANCER
  • 9.4 PROSTATE CANCER
  • 9.5 COLORECTAL CANCER
  • 9.6 LYMPHOMA
  • 9.7 LIVER CANCER
  • 9.8 THYROID CANCER
  • 9.9 BRAIN CANCER
  • 9.10 CERVICAL CANCER
  • 9.11 SPINE CANCER
  • 9.12 OTHERS

10 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITALS
  • 10.3 RADIATION THERAPY CENTERS
  • 10.4 SPECIALTY CLINICS
  • 10.5 OTHERS

11 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 OVERVIEW
  • 11.2 DIRECT TENDER
  • 11.3 RETAIL SALES
  • 11.4 OTHERS

12 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY GEOGRAPHY

  • 12.1 MIDDLE EAST AND AFRICA
    • 12.1.1 SOUTH AFRICA
    • 12.1.2 SAUDI ARABIA
    • 12.1.3 UAE
    • 12.1.4 EGYPT
    • 12.1.5 ISRAEL
    • 12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

  • 15.1 VARIAN MEDICAL SYSTEMS, INC.
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 ELEKTA AB
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 PRODUCT PORTFOLIO
    • 15.2.5 RECENT DEVELOPMENTS
  • 15.3 SIEMENS HEALTHCARE GMBH
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENTS
  • 15.4 GE HEALTHCARE
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 PRODUCT PORTFOLIO
    • 15.4.5 RECENT DEVELOPMENT
  • 15.5 ACCURAY INCORPORATED
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENT
  • 15.6 KONINKLIJKE PHILIPS N.V.
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 PRODUCT PORTFOLIO
    • 15.6.4 RECENT DEVELOPMENTS
  • 15.7 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 REVENUE ANALYSIS
    • 15.7.3 PRODUCT PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 BRAINLAB AG
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 PRODUCT PORTFOLIO
    • 15.8.3 RECENT DEVELOPMENT
  • 15.9 CIVCO RADIOTHERAPY (A SUBSIDIARY OF ROPER TECHNOLOGIES, INC.)
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 REVENUE ANALYSIS
    • 15.9.3 PRODUCT PORTFOLIO
    • 15.9.4 RECENT DEVELOPMENT
  • 15.10 ECKERT & ZIEGLER BEBIG
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 REVENUE ANALYSIS
    • 15.10.3 PRODUCT PORTFOLIO
    • 15.10.4 RECENT DEVELOPMENT
  • 15.11 HITACHI, LTD.
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 REVENUE ANALYSIS
    • 15.11.3 PRODUCT PORTFOLIO
    • 15.11.4 RECENT DEVELOPMENT
  • 15.12 IBA WORLDWIDE
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 REVENUE ANALYSIS
    • 15.12.3 PRODUCT PORTFOLIO
    • 15.12.4 RECENT DEVELOPMENT
  • 15.13 ISORAY INC.
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENT
  • 15.14 MEVION MEDICAL SYSTEMS
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 PRODUCT PORTFOLIO
    • 15.14.3 RECENT DEVELOPMENT
  • 15.15 NORDION (CANADA) INC.
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 PRODUCT PORTFOLIO
    • 15.15.3 RECENT DEVELOPMENT
  • 15.16 PROTOM INTERNATIONAL
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 PRODUCT PORTFOLIO
    • 15.16.3 RECENT DEVELOPMENT
  • 15.17 PROVISION HEALTHCARE
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 SOLUTION PORTFOLIO
    • 15.17.3 RECENT DEVELOPMENT
  • 15.18 RAYSEARCH LABORATORIES
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 REVENUE ANALYSIS
    • 15.18.3 PRODUCT PORTFOLIO
    • 15.18.4 RECENT DEVELOPMENT
  • 15.19 SUMITOMO HEAVY INDUSTRIES, LTD.
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 REVENUE ANALYSIS
    • 15.19.3 PRODUCT PORTFOLIO
    • 15.19.4 RECENT DEVELOPMENT
  • 15.20 VIEWRAY TECHNOLOGIES, INC. (A SUBSIDIARY OF VIEWRAY)
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 REVENUE ANALYSIS
    • 15.20.3 PRODUCT PORTFOLIO
    • 15.20.4 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 MIDDLE EAST AND AFRICA CANCER INCIDENCE (2018)
  • TABLE 2 MIDDLE EAST AND AFRICA CANCER INCIDENCE (2018)
  • TABLE 3 MIDDLE EAST AND AFRICA CANCER INCIDENCE (2018)
  • TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
  • TABLE 5 PRODUCT CLASSIFICATION
  • TABLE 6 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 MIDDLE EAST AND AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 MIDDLE EAST AND AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 11 MIDDLE EAST AND AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 MIDDLE EAST AND AFRICA SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 MIDDLE EAST AND AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 15 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 16 MIDDLE EAST AND AFRICA DEVICES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 MIDDLE EAST AND AFRICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 18 MIDDLE EAST AND AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 MIDDLE EAST AND AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 20 MIDDLE EAST AND AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 MIDDLE EAST AND AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 22 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 23 MIDDLE EAST AND AFRICA BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 MIDDLE EAST AND AFRICA LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 MIDDLE EAST AND AFRICA PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26 MIDDLE EAST AND AFRICA COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27 MIDDLE EAST AND AFRICA LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 MIDDLE EAST AND AFRICA LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 MIDDLE EAST AND AFRICA THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30 MIDDLE EAST AND AFRICA BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31 MIDDLE EAST AND AFRICA CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32 MIDDLE EAST AND AFRICA SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33 MIDDLE EAST AND AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 35 MIDDLE EAST AND AFRICA HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36 MIDDLE EAST AND AFRICA RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 39 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 MIDDLE EAST AND AFRICA DIRECT TENDER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 41 MIDDLE EAST AND AFRICA RETAIL SALES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 MIDDLE EAST AND AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 MIDDLE EAST AND AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 48 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 49 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 50 MIDDLE EAST AND AFRICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 51 MIDDLE EAST AND AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 52 MIDDLE EAST AND AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 53 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 54 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 55 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 56 SOUTH AFRICA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 SOUTH AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 SOUTH AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 59 SOUTH AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 SOUTH AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 61 SOUTH AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 62 SOUTH AFRICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 63 SOUTH AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 64 SOUTH AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 65 SOUTH AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 66 SOUTH AFRICA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 67 SOUTH AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 68 SAUDI ARABIA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 69 SAUDI ARABIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 SAUDI ARABIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 SAUDI ARABIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 SAUDI ARABIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 73 SAUDI ARABIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 74 SAUDI ARABIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 75 SAUDI ARABIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 76 SAUDI ARABIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 77 SAUDI ARABIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 78 SAUDI ARABIA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 79 SAUDI ARABIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 80 UAE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 81 UAE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 UAE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 83 UAE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 84 UAE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 85 UAE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 86 UAE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 87 UAE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 88 UAE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 89 UAE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90 UAE RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 UAE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 92 EGYPT RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 93 EGYPT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 94 EGYPT INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 95 EGYPT BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 96 EGYPT RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 97 EGYPT RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 98 EGYPT EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 99 EGYPT INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 100 EGYPT RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 101 EGYPT RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 102 EGYPT RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 103 EGYPT RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 104 ISRAEL RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 105 ISRAEL EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 106 ISRAEL INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 107 ISRAEL BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 108 ISRAEL RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 109 ISRAEL RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 110 ISRAEL EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 111 ISRAEL INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 112 ISRAEL RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 113 ISRAEL RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 114 ISRAEL RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 115 ISRAEL RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 116 REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
Back to Top